Table 1: Characteristics of 10 cross-sectional/case-control studies on preventive services utilization comparing cancer survivors and cancer-free controls.

Author/Year Country Type of Cancer Study Design Study Population Preventive Service Ascertainment Number of Participants Proportion of Female [%] Mean Age [years] Preventive Services NOS
Cancer Survivors / Controls
Earle et al. 2003 USA Breast cancer Matched case-control 1997-98 SEER*-Medicare Insurance claims data 5965 /
6062		 100% /
100%		 78.7 /
78.8		 During 1997-1998: Influenza vaccination, cholesterol screening, bone densitometry 8
Earle et al. 2004 USA Colorectal cancer Matched case-control 1997-98 SEER-Medicare Insurance claims data 14884 /
16559		 57.6% / 56.7% 79.7 /
79.8		 During 1997-1998: Influenza vaccination, cholesterol screening, bone densitometry 8
Duffy et al. 2005 USA Breast cancer Matched case-control MEPS† Self-reported 85 /
340		 100% /
100%		 61.7 /
63.2		 Within previous year: Influenza vaccination; within previous 5 years: cholesterol screening 5
Snyder et al. 2009 USA Stage 1-3 Breast cancer Matched case-control (matched on comorbidities) SEER-Medicare population Insurance claims data 23731 /
23396		 100% /
100%		 75.7 /
75.7		 During year 2 past cancer diagnosis: Influenza vaccination, cholesterol screening, bone densitometry 8
Khan et al. 2010 UK Breast, colorectal, prostate cancer Matched case-control GPRD‡ Medical record 29244 / 116,418 Breast:
100% / 100%
CRC: 49.5%/49.5%
Prostate:
0% / 0%		 Breast: 67.7/67.7
CRC: 75.1/75.1
Prostate:
76.9/76.9		 Annually: influenza vaccination, every 3 years: Cholesterol testing, bone density scan, blood pressure measurement 6
Fairley et al. 2010 USA All, except non-melanoma skin cancer Cross-sectional 2006 Massachusetts BRFSS§ survey data Self-reported 716 /
7375		 62.1% / 52.4% median <64 / <54 Past 12 months: Influenza vaccination 7
Bishop et al. 2010 USA Leukemic or breast cancer Matched case-control CIBTR ǂ Self-reported 662 /
158		 62% /
70%		 49.1 / 50.1 Within previous year: Influenza vaccination, blood pressure measurement 7
Snyder et al. 2011 USA Prostate cancer Matched  case-control (matched on comorbidities) 2000 SEER-Medicare Insurance claims data 10482 /
10482		 0% /
0%		 74.6 / 74.6 During month 49-60 from diagnosis: Influenza vaccination, cholesterol screening, 8
Lowenstein et al. 2015 USA All, except non-melanoma skin cancer Cross-sectional 2003 Medicare Current Beneficiary Survey Self-reported 1882 /
10133		 60.6% /
57%		 median >75 / <75 Within previous year: Influenza vaccination; within previous 6 months: cholesterol measurement, blood pressure measurement; ever received: bone mineral density, pneumonia vaccination 3
Lafata et al. 2015 USA Breast, colorectal cancer Matched case-control Tumor registries of four non-profit health systems∆ Insurance claims data 5273 /
50759		 CRC: 50%
Breast: 100%		 median <74 / <74 Annually: Lipid profile, bone densitometry for age >65 6

Abbreviations: *SEER: Surveillance, Epidemiology, and End Results Program; † MEPS: Medical Expenditure Panel Survey; ‡GPRD: General Practice Research Database; §BRFSS: Massachusetts Behavioral Risk Factor Surveillance System; ǂ CIBTR: Center for International Blood and Marrow Transplantation; ∆ tumor registries: Group Health Cooperative, Health Alliance Plan/Henry Ford Health System, Kaiser Permanente Colorado and Northwest.